Jasbello Vaginal Suppository
NDC Package 85248-042-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Jasbello Vaginal (hyaluronic acid 10mg vaginal suppositories) suppositories is insert one JASBELLO suppository high into the vaginafor once every 2-3 nights.Applicators are included for ease of use. This formulation utilizes a suppository delivery system. Marketed by Jiangxi Yudexi Pharmaceutical Co., Ltd, this product is identified by NDC 85248-042.

Identification & Billing

NDC Package Code
85248-042-01
Package Description
12 BLISTER PACK in 1 BOX / 2 g in 1 BLISTER PACK
Product Code
85248-042
11-Digit Billing Format
85248004201

Clinical Specifications

Proprietary Name
Jasbello Vaginal
Non-Proprietary Name
Hyaluronic Acid 10mg Vaginal Suppositories
Substance Name
Hyaluronic Acid
Dosage Form
Suppository - A solid body of various weights and shapes, adapted for introduction into the rectal orifice of the human body; they usually melt, soften, or dissolve at body temperature.
Administration Route
Vaginal - Administration into the vagina.
Active Ingredient(s)
HYALURONIC ACID 10 mg/g
Usage Information
Insert one JASBELLO suppository high into the vaginafor once every 2-3 nights.Applicators are included for ease of use.

Regulatory & Marketing

Labeler Name
Jiangxi Yudexi Pharmaceutical Co., Ltd
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
02-03-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 85248-042-01 identifies a specific commercial package of 12 blister pack in 1 box / 2 g in 1 blister pack of Jasbello Vaginal, a human over the counter drug labeled by Jiangxi Yudexi Pharmaceutical Co., Ltd. This suppository is formulated for vaginal use and contains hyaluronic acid as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Jiangxi Yudexi Pharmaceutical Co., Ltd on February 03, 2026. The current certification is valid through December 31, 2027.

How is this Jiangxi Yudexi Pharmaceutical Co., Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 85248004201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
85248-042-01
11-Digit CMS (5-4-2)
85248-0042-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.